1Nakanuma Y, Harada K, Ishikawa A, et al. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma[J]. J Hepatobiliary Pantreat Surg, 2003,10(4):265-281.
2Ahrendt SA, Rashid A, Chow JT, et al. p53 overexpression and K- rans gene mutations primary sclerosing cholangitis-associated biliary tract[J].J Hepatobiliaty Pancreat Surg, 2000,7 (4):426-431.
3Ishikawa A, Sasaki M, Sato Y, et al. Frequent p16ink4a inactivation is an early and frequent event intraductal papillary neoplasm of the liver arising in hepatolithiasis[J]. Hum Pathol, 2004,35 (12):1505- 1514.
4Klump B, Hsieh CJ, Nehls O, et al. Methylation status of p14ARF and p16INK4a as detected in pancreatic secretions [J]. Br J Cancer, 2003,88(2):217-222.
5Kuroki T, Trapasso F, Yendamuri S, et al. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma [J]. Clin Cancer Res, 2003,9(4):1441.
6Kuroki T, Trapasso F, Yendamuri Set al. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of Semaphorin 3B in non-small cell cancer[J]. Cancer Res, 2003,63 ( 12):3352-3355.
7Tsuchida A, Nagakawa Y, Kasuya K, et al. Immunohistochemical analysis of cyclooxygenase-2 and vascular endothelial growth factor in pancreaticobiliary maljunction[J]. Oncol Rep, 2003,10(2):339-343.
8Endo K, Yoon BI, Pairojkul C, et al. ERBB- 2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions[J]. Hepatology, 2002,36(2):439-450.
9Tsuneoka N, Tajima Y, Kitazato A, et al. Chemopreventstive effect of a cyclooxygenase-2-specific inhibitor (etodolac) on chemically induced biliary carcinogenesis in hamsters[J]. Carcinogenesis, 2005,26(2):465-469.
10Shoda J, Ueda T, Kawamoto T, et al. Prostaglandin E receptors in bile ducts of hepatolithiasis patients and the pathobiological significance for cholangitis[J]. Clin Gastroenterol Hepatol, 2003,1 (4):285-296.
1Bai-He Zhang, Qing-Bao Cheng, Xiang-Ji Luo, Yong-Jie Zhang, Xiao-Qing Jiang, Bao-Hua Zhang, Bin Yi, Wen-Long Yu and Meng-Chao Wu Department of Biliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.Surgical therapy for hiliar cholangiocarcinonia:analysis of 198 cases[J].Hepatobiliary & Pancreatic Diseases International,2006,5(2):278-282. 被引量：5
